Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi
- 1 October 2007
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 30 (5), 464-469
- https://doi.org/10.1111/j.1365-2885.2007.00896.x
Abstract
The objective of the present study was to determine the antimicrobial susceptibility of 136 canine isolates of Staphylococcus intermedius and 10 canine isolates of S. schleiferi subspecies coagulans to 16 fluoroquinolones (FQs), and to investigate the mechanisms of resistance in the nonsusceptible isolates. Of the 136 of S. intermedius tested 98.5% were susceptible to all 16 FQs whereas only 40% of the 10 isolates of S. schleiferi subspecies coagulans were susceptible. Two isolates of S. intermedius and six isolates of S. schleiferi, were found to be resistant to 13 out of 16 FQs, while they retained their susceptibility to fourth generation FQs such as gatifloxacin, moxifloxacin and trovafloxacin. Sequencing of the quinolone-resistance determining regions of gyrA and grlA genes showed that in S. intermedius, dichotomous resistance to FQs was associated with the occurrence of one alteration in GyrA-84 and one in GrlA-80, while in S. schleiferi the same pattern of resistance was observed in isolates showing these changes only in gyrA. This study is the first to screen FQs of the second, third and fourth generation for antimicrobial resistance in clinical isolates of S. intermedius and S. schleiferi of canine origin, and to describe mutations in gyrA and grlA associated with FQ resistance in these bacterial speciesKeywords
This publication has 36 references indexed in Scilit:
- Mechanisms of Resistance to QuinolonesClinical Infectious Diseases, 2005
- Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyodermaVeterinary Microbiology, 2005
- Human-to-Dog Transmission of Methicillin-ResistantStaphylococcus aureusEmerging Infectious Diseases, 2004
- Development and Evaluation of a Quality-Controlled Ribosomal Sequence Database for 16S Ribosomal DNA-Based Identification of Staphylococcus SpeciesJournal of Clinical Microbiology, 2004
- Treatment of canine pyoderma with ibafloxacin and marbofloxacin - fluoroquinolones with different pharmacokinetic profilesJournal of Veterinary Pharmacology and Therapeutics, 2004
- Fluoroquinolones: mechanism of action, classification, and development of resistanceSurvey of Ophthalmology, 2004
- RIDOM: Ribosomal Differentiation of Medical Micro-organisms DatabaseNucleic Acids Research, 2002
- Mechanisms of Action of Antimicrobials: Focus on FluoroquinolonesClinical Infectious Diseases, 2001
- Fluoroquinolone resistance in Staphylococcus intermediusVeterinary Dermatology, 1999
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999